Author:
Yan Huimeng,Huang Jinyuan,Li Yingying,Zhao Bin
Reference62 articles.
1. Intermediate endpoints as surrogates for outcomes in cancer immunotherapy: a systematic review and meta-analysis of phase 3 trials;Z Zhang;EClinicalMedicine,2023
2. Esophagogastric Cancers: Integrating Immunotherapy Therapy Into Current Practice;M A Patel;Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2022
3. Sex dimorphism in the tumor microenvironment -From bench to bedside and back;F He;Seminars in cancer biology,2022
4. Advances in sex disparities for cancer immunotherapy: unveiling the dilemma of Yin and Yang;J Ma;Biology of sex differences,2022